All posts

PayPal’s best days are behind it, this portfolio manager says

Lorne Steinberg
Investors thinking of jumping aboard the high-flying PayPal Holdings (PayPal Holdings Stock Quote, Chart NASDAQ:PYPL) might want to reconsider their options. According to portfolio manager Lorne Steinberg, increasing competition in the fast-evolving fintech space spells trouble.

PayPal has been on a tear in 2019, hitting new all-time highs by late January and not stopping since. So far, PYPL is up 29 per cent year-to-date. Further, the company’s latest earnings report told the tale of substantial top line growth, coming in with Q1 revenue of $4.13 billion, a 12-per-cent growth rate, to go along with GAAP EPS of $0.56 per share. (All figures in US dollars.)

What’s more, PayPal grew its net active accounts by 9.3 million, a 17-per-cent increase, while the company chose to repurchase 7.7 million shares, returning $750 million to stockholders. And since the April 24 earnings release, PayPal has splurged big time, putting $750 million into Argentina’s e-commerce company MercadoLibre and another $500 million into Uber.

So, all those strong numbers and impressive investments should have investors feeling great about PayPal’s prospects, right? Not really, says Steinberg, who sees unfavourable developments on the macro scale.

“This is becoming a crowded field,” said Steinberg, president of Lorne Steinberg Wealth Management, to BNN Bloomberg on Tuesday. “PayPal has done a fantastic job but, of course, Apple Pay is no slouch. I was in a taxicab the other day and they’re using other devices, other types of pays, and so it’s becoming a crowded trade.”

“How that plays out is hard to say but the concept of people using their phones more and more to buy things, I think that PayPal has probably seen its best growth behind it just because of increasing competition and the move to mobile,” he says.

Steinberg points to China where Alibaba’s Alipay and WeChat Pay have locked up the mobile and online payment market, leaving little room for PayPal to expand. Ultimately, Steinberg sees the credit card companies, including PayPal’s partnership with Visa, as likely losers in the emerging fintech environment.

“Retailers don’t like credit cards, and they would much rather use debit and instead of paying two per cent, they pay a fraction of one per cent, and consumers will ultimately benefit from that as well,” he says. “I don’t like to bet against that which is better for consumers over time because everybody is driving margins and pricing down.”

“So we would certainly stay away from this stock at this point in time,” he said.

Tagged with: pypl
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Air Canada stock is a buy, Citi says

Don't worry about it. That's the takeaway from a recent report by Citi analyst Stephen Trent on Air Canada (Air… [Read More]

1 day ago

CIBC says BlackBerry is a buy

Following first quarter results that were cheered by the street, CIBC analyst Todd Coupland has maintained his "Buy" rating and… [Read More]

2 days ago

Hydreight Technologies is an interesting stock, this analyst says

Hydreight Technologies (Hydreight Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:NURS) is accelerating its efforts to build what it calls… [Read More]

3 days ago

TeraWulf earns price target raise at Roth

Roth Capital Markets analyst Darren Aftahi raised his price target on TeraWulf (TeraWulf Stock Quote, Chart, News, Analysts, Financials NASDAQ:WULF)… [Read More]

3 days ago

Haywood raises price target on Tornado Infrastructure Equipment

Haywood Capital Markets analyst Gianluca Tucci raised his target price on Tornado Infrastructure Equipment (Tornado Infrastructure Equipment Stock Quote, Chart,… [Read More]

4 days ago

Medexus Pharmaceuticals is a buy, Research Capital says

Research Capital analyst Andre Uddin maintained a “Buy” rating and C$5.55 price target on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote,… [Read More]

5 days ago